These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32892574)

  • 1. [NTRK fusion gene expression in solid tumors and research progress of Trk small molecule inhibitors].
    Yue JQ; Cai L; Li JL; Guan WB; Wang RF; Yu WW; Wang LF
    Zhonghua Bing Li Xue Za Zhi; 2020 Sep; 49(9):972-976. PubMed ID: 32892574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [NTRK Gene Fusions and Treatment in NTRK Fusion-Positive Solid Cancers].
    Fukuda M; Naito Y
    Gan To Kagaku Ryoho; 2022 Oct; 49(10):1048-1050. PubMed ID: 36281593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis and therapy of tumors with NTRK gene fusion].
    Stenzinger A; van Tilburg CM; Tabatabai G; Länger F; Graf N; Griesinger F; Heukamp LC; Hummel M; Klingebiel T; Hettmer S; Vokuhl C; Merkelbach-Bruse S; Overkamp F; Reichardt P; Scheer M; Weichert W; Westphalen CB; Bokemeyer C; Ivanyi P; Loges S; Schirmacher P; Wörmann B; Bielack S; Seufferlein TTW
    Pathologe; 2021 Feb; 42(1):103-115. PubMed ID: 33258061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NTRK fusions in thyroid cancer: Pathology and clinical aspects.
    Ma Y; Zhang Q; Zhang K; Liang Y; Ren F; Zhang J; Kan C; Han F; Sun X
    Crit Rev Oncol Hematol; 2023 Apr; 184():103957. PubMed ID: 36907364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment Patterns of Real-World Patients with TRK Fusion Cancer Treated by US Community Oncologists.
    Klink AJ; Kavati A; Gassama A; Kozlek T; Gajra A; Antoine R
    Target Oncol; 2022 Sep; 17(5):549-561. PubMed ID: 36089643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canadian consensus on TRK-inhibitor therapy for NTRK fusion-positive sarcoma.
    Simmons C; Deyell RJ; MacNeill AJ; Vera-Badillo FE; Smrke A; Abdul Razak AR; Banerji S; McLeod D; Noujaim J
    Int J Cancer; 2021 Nov; 149(9):1691-1704. PubMed ID: 34213775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotrophic tyrosine receptor kinase fusion in pediatric central nervous system tumors.
    Lang SS; Kumar NK; Madsen P; Gajjar AA; Gajjar E; Resnick AC; Storm PB
    Cancer Genet; 2022 Apr; 262-263():64-70. PubMed ID: 35108662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase separation underlies signaling activation of oncogenic NTRK fusions.
    Zhu T; Xie J; He H; Li H; Tang X; Wang S; Li Z; Tian Y; Li L; Zhu J; Zhu G
    Proc Natl Acad Sci U S A; 2023 Oct; 120(42):e2219589120. PubMed ID: 37812694
    [No Abstract]   [Full Text] [Related]  

  • 9. Improving outcomes in pediatric NTRK gene fusion-positive solid tumors: importance of genomic testing and targeted therapy with the TRK inhibitor larotrectinib.
    Laetsch TW
    Clin Adv Hematol Oncol; 2024 May; 22 Suppl 3(4):1-11. PubMed ID: 38739704
    [No Abstract]   [Full Text] [Related]  

  • 10. Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology.
    Naito Y; Mishima S; Akagi K; Igarashi A; Ikeda M; Okano S; Kato S; Takano T; Tsuchihara K; Terashima K; Nishihara H; Nishiyama H; Hiyama E; Hirasawa A; Hosoi H; Maeda O; Yatabe Y; Okamoto W; Ono S; Kajiyama H; Nagashima F; Hatanaka Y; Miyachi M; Kodera Y; Yoshino T; Taniguchi H
    Int J Clin Oncol; 2020 Mar; 25(3):403-417. PubMed ID: 31974683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [NTRK Fusions: A new way of treatment for gastro-intestinal tumor?].
    Ouali K; Pellat A; Cohen R; Svrcek M; Penault-Llorca F; André T
    Bull Cancer; 2020 Apr; 107(4):447-457. PubMed ID: 32067719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTRK insights: best practices for pathologists.
    Hechtman JF
    Mod Pathol; 2022 Mar; 35(3):298-305. PubMed ID: 34531526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of
    Cuello M; García-Rivello H; Huamán-Garaicoa F; Irigoyen-Piñeiros P; Lara-Torres CO; Rizzo MM; Ticona-Castro M; Trejo R; Zoroquiain P
    Future Oncol; 2023 Dec; 19(40):2669-2682. PubMed ID: 38088163
    [No Abstract]   [Full Text] [Related]  

  • 14. Pan-TRK Immunohistochemistry to Optimize the Detection of NTRK Fusions: Removing the Hay When Looking for the Needle.
    Conde E; Hernandez S; Alonso M; Lopez-Rios F
    Mod Pathol; 2023 Dec; 36(12):100346. PubMed ID: 37757968
    [No Abstract]   [Full Text] [Related]  

  • 15. Identifying patients with NTRK fusion cancer.
    Solomon JP; Benayed R; Hechtman JF; Ladanyi M
    Ann Oncol; 2019 Nov; 30(Suppl_8):viii16-viii22. PubMed ID: 31738428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study.
    Laetsch TW; DuBois SG; Mascarenhas L; Turpin B; Federman N; Albert CM; Nagasubramanian R; Davis JL; Rudzinski E; Feraco AM; Tuch BB; Ebata KT; Reynolds M; Smith S; Cruickshank S; Cox MC; Pappo AS; Hawkins DS
    Lancet Oncol; 2018 May; 19(5):705-714. PubMed ID: 29606586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from Tyrosine Kinase (TRK) Inhibitor Therapy.
    Hsiao SJ; Zehir A; Sireci AN; Aisner DL
    J Mol Diagn; 2019 Jul; 21(4):553-571. PubMed ID: 31075511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent
    Khuong-Quang DA; Brown LM; Wong M; Mayoh C; Sexton-Oates A; Kumar A; Pinese M; Nagabushan S; Lau L; Ludlow LE; Gifford AJ; Rodriguez M; Desai J; Fox SB; Haber M; Ziegler DS; Hansford JR; Marshall GM; Cowley MJ; Ekert PG
    Cold Spring Harb Mol Case Stud; 2020 Dec; 6(6):. PubMed ID: 33144287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of
    Zhang HD; Yin XN; Cai ZL; Zhang B
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):769-774. PubMed ID: 34530557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research Progress on Small Molecules Inhibitors Targeting TRK Kinases.
    Liu J; Zhang Y; Zhu Y; Tian L; Tang M; Shen J; Chen Y; Ding S
    Curr Med Chem; 2023; 30(10):1175-1192. PubMed ID: 35927900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.